SKAFF MICHAEL C purchased 1.35M shares of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.81M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/2/2026ACC: 0002074003-26-000008
+5.35M
Net shares
Net buyer
$1.81M
Total acquired
2
Open market trades
2B · 0S
5
Total transactions
5.35M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.04M
Price / share
$1.34
Trade value
$1.40M
% of position
New position
3/31/2026
0.00→1.04M
Common Stock
Indirect
Shares
+308.85K
Price / share
$1.34
Trade value
$413.86K
% of position
29.6%
3/31/2026
1.04M→1.35M
Total
Net shares
+1.35M
Net value
$1.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/31/2026 | P · Purchase | +1.04M | $1.34 | $1.40M | New position | 0.00 | 1.04M |
| Common Stock Indirect | 3/31/2026 | P · Purchase | +308.85K | $1.34 | $413.86K | 29.6% | 1.04M | 1.35M |
| Total | +1.35M | $1.81M | ||||||
Derivative Transactions3
Pre-Funded Warrant
Indirect
Converts to
Common Stock
429.96K shares
Shares
+429.96K
Strike price
0.0001
Held after
429.96K
Exercisable
—
3/31/2026
Series A Common Stock Warrant
Indirect
Converts to
Common Stock
1.78M shares
Shares
+1.78M
Strike price
1.09
Held after
1.78M
Exercisable
—
3/31/2026
Series B Common Stock Warrant
Indirect
Converts to
Common Stock
1.78M shares
Shares
+1.78M
Strike price
1.09
Held after
1.78M
Exercisable
—
3/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrant Indirect | Common Stock429.96K shares | 3/31/2026 | P · Purchase | +429.96K | 0.0001 | — | 429.96K |
| Series A Common Stock Warrant Indirect | Common Stock1.78M shares | 3/31/2026 | P · Purchase | +1.78M | 1.09 | — | 1.78M |
| Series B Common Stock Warrant Indirect | Common Stock1.78M shares | 3/31/2026 | P · Purchase | +1.78M | 1.09 | — | 1.78M |